Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wisniewski

Showing results (71-80 of 3,655) with videos related to

Pageof 366
Sort By:
Neuroscience Letters|February 3, 1992
Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloidT Wisniewski, B Frangione
Lancet (London, England)|August 12, 1995
Amyloidosis in Alzheimer's diseaseT Wisniewski, B Frangione
Wisconsin Medical Journal|November 1, 1996
Internet Web resources for anti-tobacco advocacyK Miller, S Wisniewski
Acta Neuropathologica|December 28, 2016
Alzheimer's disease: experimental models and realityEleanor Drummond, Thomas Wisniewski
Molecular Neurobiology|January 1, 1992
Molecular biology of Alzheimer's amyloid--Dutch variantT Wisniewski, B Frangione
International Journal of Cell Biology|November 14, 2013
The innate immune system in Alzheimer's diseaseAllal Boutajangout, Thomas Wisniewski
International Urology and Nephrology|January 1, 1972
Dorsal approach in the surgery of kidneys and of the upper portion of the ureterJ Wisniewski, L Jeromin
Pharmacology|January 1, 1977
The effect of prostaglandin E1 on central cholinergic mechanismsA Bodzenta, K Wisniewski
Expert Review of Vaccines|November 19, 2015
Developing therapeutic vaccines against Alzheimer's diseaseThomas Wisniewski, Eleanor Drummond
International Journal of Alzheimer'S Disease|July 31, 2012
Apolipoprotein e: essential catalyst of the Alzheimer amyloid cascadeHuntington Potter, Thomas Wisniewski
Pageof 366

Showing results (71-80 of 3,655) with videos related to

Sort By:
Pageof 366
Neuroscience Letters|February 3, 1992
Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloidT Wisniewski, B Frangione
Lancet (London, England)|August 12, 1995
Amyloidosis in Alzheimer's diseaseT Wisniewski, B Frangione
Wisconsin Medical Journal|November 1, 1996
Internet Web resources for anti-tobacco advocacyK Miller, S Wisniewski
Acta Neuropathologica|December 28, 2016
Alzheimer's disease: experimental models and realityEleanor Drummond, Thomas Wisniewski
Molecular Neurobiology|January 1, 1992
Molecular biology of Alzheimer's amyloid--Dutch variantT Wisniewski, B Frangione
International Journal of Cell Biology|November 14, 2013
The innate immune system in Alzheimer's diseaseAllal Boutajangout, Thomas Wisniewski
International Urology and Nephrology|January 1, 1972
Dorsal approach in the surgery of kidneys and of the upper portion of the ureterJ Wisniewski, L Jeromin
Pharmacology|January 1, 1977
The effect of prostaglandin E1 on central cholinergic mechanismsA Bodzenta, K Wisniewski
Expert Review of Vaccines|November 19, 2015
Developing therapeutic vaccines against Alzheimer's diseaseThomas Wisniewski, Eleanor Drummond
International Journal of Alzheimer'S Disease|July 31, 2012
Apolipoprotein e: essential catalyst of the Alzheimer amyloid cascadeHuntington Potter, Thomas Wisniewski
Pageof 366